Nchi: Kanada
Lugha: Kiingereza
Chanzo: Health Canada
LEVOCARNITINE
LEADIANT BIOSCIENCES, INC
A16AA01
LEVOCARNITINE
100MG
SOLUTION
LEVOCARNITINE 100MG
ORAL
118ML
Prescription
CALORIC AGENTS
Active ingredient group (AIG) number: 0127168003; AHFS:
APPROVED
2017-11-02
CARNITOR ® Product Monograph Page 1 of 26 PRODUCT MONOGRAPH Pr CARNITOR ® Levocarnitine Tablets USP 330 mg Levocarnitine Oral Solution USP 1 g / 10 mL (100 mg / mL) Levocarnitine Injection USP 1 g / 5 mL (200 mg / mL) Amino Acids and Derivatives Leadiant Biosciences, Inc. 2000 Ellesmere Road, Unit 16 Scarborough, Ontario M1H 2W4 Date of Revision: April 23, 2019 Submission Control No: 222342 CARNITOR ® Product Monograph Page 2 of 26 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ....................................................................... 3 SUMMARY PRODUCT INFORMATION ..................................................................................... 3 INDICATIONS AND CLINICAL USE ........................................................................................... 3 CONTRAINDICATIONS ................................................................................................................ 4 WARNINGS AND PRECAUTIONS ............................................................................................... 4 ADVERSE REACTIONS ................................................................................................................. 6 DRUG INTERACTIONS ............................................................................................................... 12 DOSAGE AND ADMINISTRATION ........................................................................................... 12 OVERDOSAGE ............................................................................................................................. 14 ACTION AND CLINICAL PHARMACOLOGY ......................................................................... 15 STORAGE AND STABILITY ....................................................................................................... 17 DOSAGE FORMS, COMPOSITION AND PACKAGING .......................................................... 17 PART II: SCIENTIFIC INFORMATION ................................................................................. Soma hati kamili